Institution scientifique

Johnson & Johnson (United States)

New Brunswick · US · company

14917Publications signalées

1567810Citations signalées

12Thèmes principaux

Principaux domaines

Health Systems, Economic Evaluations, Quality of LifeMultiple Myeloma Research and TreatmentsStatistical Methods in Clinical TrialsComputational Drug Discovery MethodsPsoriasis: Treatment and PathogenesisBiosimilars and Bioanalytical MethodsAtrial Fibrillation Management and OutcomesMonoclonal and Polyclonal Antibodies ResearchOcular Surface and Contact LensSchizophrenia research and treatmentAnalytical Chemistry and ChromatographyReceptor Mechanisms and Signaling

Évolution annuelle

1996112

1998130

1999120

2000146

2001144

2002270

2003405

2004525

2005453

2006520

2007541

2008530

2009487

2010543

2011492

2012405

2013298

2014268

2015283

2016346

2017272

2018365

2019408

2020398

2021396

2022481

2023535

2024657

20251289

20261065

Publications récentes

Accès ouvert 2026 dataset

Available datapackage for study 'A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNF a Chimeric Monoclonal Antibody (Infliximab, REMICADE) in Pediatric Subjects With Moderate to Severe CROHN'S Disease.'

Johnson & Johnson

0 citationsVivli

2026 article

Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study

Derek de Winter, Kenneth J Moise, Leona E Ling, Dick Oepkes et autres

0 citationsArchives of Disease in Childhood Fetal & Neonatal

Accès ouvert 2026 article

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real‐World Data: The INVESTED‐Medicare Linkage Study

Hanseul Cho, HoJin Shin, Mehdi Najafzadeh, Brian Claggett et autres

0 citationsClinical Pharmacology & Therapeutics

Accès ouvert 2026 article

Comparison of two self-reported tools for assessment of sleep quality

Melissa J. Benton, Andrea M. Hutchins

0 citationsPatient Related Outcome Measures

Accès ouvert 2026 article

Long-term safety and tolerability of lumateperone 42 mg in patients with stable symptoms of schizophrenia: Results from a 1-year open-label study

Christoph U. Correll, Suresh Durgam, Susan G. Kozauer, Changzheng Chen et autres

0 citationsSchizophrenia Research

Accès ouvert 2026 article

A Qualitative Study of Patient and Caregiver Perspectives on Locally Advanced Head and Neck Cancer in the United States

Esther Yu, Veronica Ashton, Oluyemisi Falope, Toby Hanna et autres

0 citationsOncology and Therapy

Accès ouvert 2026 article

Secondary use and scholarly impact of a portfolio of clinical trials with shared individual participant level data: cross sectional study

Erfan Taherifard, Maryam Mooghali, Hollin R.L. Hakimian, Sahil R. Mane et autres

1 citationBMJ

Accès ouvert 2026 article

Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study

Paula Rodríguez‐Otero, Daniel Morillo, Anita D'Souza, Donna Reece et autres

0 citationsBlood Advances

Accès ouvert 2026 article

Real-world treatment patterns and disease burden in generalized myasthenia gravis patients receiving non-steroidal immunosuppressants within the Brazilian public health system: a claims database study

Acary Souza Bulle Oliveira, Marcondes Cavalcante França, Paulo Victor Sgobbi de Souza, Ligia Coelho et autres

0 citationsBMC Neurology

Accès ouvert 2026 dataset

A Phase 3 Open-label Randomized Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women

Johnson & Johnson

0 citationsVivli

Accès ouvert 2026 article

Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience

Gang An, Jie Jin, Zhen Cai, Hongmei Jing et autres

0 citationsHematology

Accès ouvert 2026 article

A Prospective, Multi-Center, Randomized Controlled Study to Evaluate the Efficacy and Safety of Two Absorbable Barbed Sutures in Thyroid Surgery

Xiuhe Zou, Ting Zhang, Wenxin Zhao, Yijun Wu et autres

0 citationsMedical Devices Evidence and Research

Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.